Literature DB >> 15021884

Ubiquitin-like protein activation.

Danny T Huang1, Helen Walden, David Duda, Brenda A Schulman.   

Abstract

Post-translational covalent attachment of ubiquitin and ubiquitin-like proteins (ubls) has emerged as a predominant cellular regulatory mechanism, with important roles in controlling cell division, signal transduction, embryonic development, endocytic trafficking and the immune response. Ubls function by remodeling the surface of their target proteins, changing their target's half-life, enzymatic activity, protein-protein interactions, subcellular localization or other properties. At least 10 different ubiquitin-like modifications exist in mammals, and attachment of different ubls to a target leads to different biological consequences. Ubl-conjugation cascades are initiated by activating enzymes, which also coordinate the ubls with their downstream pathways. A number of biochemical and structural studies have provided insights into the mechanism of ubl-activating enzymes and their roles in ubl conjugation cascades.

Mesh:

Substances:

Year:  2004        PMID: 15021884     DOI: 10.1038/sj.onc.1207393

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  27 in total

1.  E1-E2 interactions in ubiquitin and Nedd8 ligation pathways.

Authors:  Zeynep Tokgöz; Thomas J Siepmann; Frederick Streich; Brajesh Kumar; Jennifer M Klein; Arthur L Haas
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

2.  Structures of the SUMO E1 provide mechanistic insights into SUMO activation and E2 recruitment to E1.

Authors:  Luisa Maria Lois; Christopher D Lima
Journal:  EMBO J       Date:  2005-01-20       Impact factor: 11.598

3.  The Prp19 U-box crystal structure suggests a common dimeric architecture for a class of oligomeric E3 ubiquitin ligases.

Authors:  Craig W Vander Kooi; Melanie D Ohi; Joshua A Rosenberg; Michael L Oldham; Marcia E Newcomer; Kathleen L Gould; Walter J Chazin
Journal:  Biochemistry       Date:  2006-01-10       Impact factor: 3.162

4.  Functional anthology of intrinsic disorder. 3. Ligands, post-translational modifications, and diseases associated with intrinsically disordered proteins.

Authors:  Hongbo Xie; Slobodan Vucetic; Lilia M Iakoucheva; Christopher J Oldfield; A Keith Dunker; Zoran Obradovic; Vladimir N Uversky
Journal:  J Proteome Res       Date:  2007-03-29       Impact factor: 4.466

5.  Functional anthology of intrinsic disorder. 1. Biological processes and functions of proteins with long disordered regions.

Authors:  Hongbo Xie; Slobodan Vucetic; Lilia M Iakoucheva; Christopher J Oldfield; A Keith Dunker; Vladimir N Uversky; Zoran Obradovic
Journal:  J Proteome Res       Date:  2007-03-29       Impact factor: 4.466

6.  Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression.

Authors:  Toru Kubota; Mayumi Matsuoka; Tsung-Hsien Chang; Prafullakumar Tailor; Tsuguo Sasaki; Masato Tashiro; Atsushi Kato; Keiko Ozato
Journal:  J Biol Chem       Date:  2008-07-17       Impact factor: 5.157

7.  Multimodal mechanism of action for the Cdc34 acidic loop: a case study for why ubiquitin-conjugating enzymes have loops and tails.

Authors:  Amy Ziemba; Spencer Hill; Daniella Sandoval; Kristofor Webb; Eric J Bennett; Gary Kleiger
Journal:  J Biol Chem       Date:  2013-10-15       Impact factor: 5.157

8.  Mono-ubiquitination drives nuclear export of the human DCN1-like protein hDCNL1.

Authors:  Kenneth Wu; Hua Yan; Lei Fang; Xinjiang Wang; Cathie Pfleger; Xuejun Jiang; Lan Huang; Zhen-Qiang Pan
Journal:  J Biol Chem       Date:  2011-08-03       Impact factor: 5.157

Review 9.  The enzymes in ubiquitin-like post-translational modifications.

Authors:  Yuan Chen
Journal:  Biosci Trends       Date:  2007-08       Impact factor: 2.400

Review 10.  Poised for success: implementation of sound conditioning strategies to promote endogenous protective responses to stroke in patients.

Authors:  Bethann McLaughlin; Jeff M Gidday
Journal:  Transl Stroke Res       Date:  2013-01-11       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.